UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
VERU
Veru Inc.
There isn't enough reported data to score VERU yet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
VERU Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
VERU's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
VERU PE Valuation
VERU has no meaningful PE right now: it lost money over the past year.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
VERU Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| -- | |
| -- | |
| Limited | |
| Low |
Analysts expect VERU's losses to shrink, with revenue holding steady. However, they disagree widely on these estimates.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over VERU on earnings quality, reporting a profit while its opponent remains loss making.
VERU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.58 | +$1.65 |
| Q1 2026 | -$0.78 | +$1.65 |
| Q4 2025 | -$1.16 | +$1.47 |
| Q3 2025 | -$1.50 | +$1.33 |
| Q2 2025 | -$2.23 | +$0.57 |
| Q1 2025 | -$2.43 | +$0.47 |
| Q4 2024 | -$2.63 | +$4.37 |
| Q3 2024 | -$2.83 | +$7.97 |
VERU is still losing money, but far less than before: $0.58 per share over the past year, against $17.30 at its worst in early 2023.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the stronger quarterly revenue trend. Revenue is down 0.4% for UNH versus down 100% for VERU.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
VERU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2024 | $6.7M | +72% |
| Q2 2024 | $4M | +18% |
| Q1 2024 | $4.1M | -37% |
| Q4 2023 | $2.1M | -15% |
| Q3 2023 | $3.9M | +49% |
| Q2 2023 | $3.3M | -65% |
| Q1 2023 | $6.6M | -49% |
| Q4 2022 | $2.5M | -82% |
VERU's revenue has slid since its 2021 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2024 | -123% | +88 points |
| Q2 2024 | -277% | -41 points |
| Q1 2024 | -239% | +359 points |
| Q4 2023 | -368% | +1051 points |
| Q3 2023 | -212% | +1514 points |
| Q2 2023 | -236% | -8.4 points |
| Q1 2023 | -599% | -508 points |
| Q4 2022 | -1419% | -1384 points |
VERU's operating margin was −123% last quarter, up 88 points from the same quarter a year ago.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over VERU on cash generation, producing positive trailing cash flow while its opponent burns cash.
VERU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$5.5M | +$15.1K |
| Q1 2026 | -$8.9M | -$1.2M |
| Q4 2025 | -$6.2M | +$5.2M |
| Q3 2025 | -$5.5M | -$1.1M |
| Q2 2025 | -$5.5M | +$218.1K |
| Q3 2024 | -$4.4M | +$5.3M |
| Q2 2024 | -$5.7M | +$12.8M |
| Q3 2023 | -$9.7M | +$11.3M |
VERU has burned cash in almost every quarter: −$26M over the past year, against −$29M the year before.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over VERU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
VERU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +57% | +8.4M shares |
| 3 years | +161% | +14.2M shares |
| 5 years | +189% | +15.1M shares |
| Available history | +264% | +16.7M shares |
VERU has 23M diluted shares, up 57% from a year ago.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
VERU Net Leverage
VERU's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
VERU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 9.7 | Oversold |
VERU's weekly RSI is 39 (neutral) and its Stochastic is 10 (oversold).
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
VERU PE vs Healthcare Sector
VERU has no meaningful PE right now: it lost money over the past year.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over VERU on trend strength, trading above more of its moving averages.
VERU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.31 | 8.2% below |
| 20 week MA | $2.45 | 13% below |
| 50 week MA | $2.47 | 14% below |
| 100 week MA | $3.78 | 44% below |
| 200 week MA | $7.98 | 73% below |
VERU is in a downtrend: it's below all five of its weekly moving averages, and 73% below its 200-week average.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over VERU on returns for 2026, with the stronger performance.
VERU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.3 | $86.7 | +186% |
| 2021 | $86.7 | $62.9 | -27% |
| 2022 | $62.9 | $50.5 | -20% |
| 2023 | $50.5 | $7.20 | -86% |
| 2024 | $7.20 | $6.76 | -6.1% |
| 2025 | $6.76 | $2.40 | -64% |
| 2026 YTD | $2.40 | $2.12 | -12% |
VERU has finished five years in a row lower, and it's down 12% so far in 2026.